Managing Desaturations in Patients
For patients experiencing desaturation, immediately initiate oxygen therapy targeting SpO2 94-98% for most patients, but 88-92% for those with COPD or risk factors for hypercapnic respiratory failure, using controlled delivery devices and checking arterial blood gases within 30-60 minutes to guide further management. 1
Initial Assessment and Oxygen Delivery
Verify Equipment and Patient Factors First
- Confirm the pulse oximeter is correctly placed and functioning normally before assuming true desaturation 1
- Check that the oxygen delivery device and flow rate are correct 1
- If using a cylinder, verify it contains oxygen (check labeling) and is not empty or near-empty 1
- Position fully conscious hypoxaemic patients upright rather than supine, as oxygenation is reduced in the supine position 1
Choose Initial Oxygen Delivery Based on Severity and Risk
For patients WITHOUT COPD or hypercapnic risk:
- If SpO2 <85%: Use reservoir mask at 15 L/min 1
- If SpO2 ≥85%: Use nasal cannulae at 2-6 L/min or simple face mask at 5-10 L/min 1
- Target SpO2 94-98% 1
For patients WITH COPD or hypercapnic risk factors (morbid obesity, cystic fibrosis, chest wall deformities, neuromuscular disorders, bronchiectasis with fixed airflow obstruction):
- Start with 24% Venturi mask at 2-3 L/min, OR 28% Venturi mask at 4 L/min, OR nasal cannulae at 1-2 L/min 1, 2, 3
- Target SpO2 88-92% pending blood gas results 1, 2
- Never target >92% in CO2-retaining patients, as this significantly increases mortality risk 2
Critical Timing for Blood Gas Assessment
- Obtain arterial blood gases within 30-60 minutes of initiating oxygen therapy (or sooner if clinical deterioration) for all patients at risk of hypercapnic respiratory failure 1, 2, 3
- Check that supplemental oxygen achieves PaO2 >8 kPa without unacceptable rise in PaCO2 1
- PaO2 >10 kPa (75 mmHg) indicates excessive oxygen therapy and increases respiratory acidosis risk 2, 3
Management Algorithm Based on Blood Gas Results
If pH and PCO2 are Normal:
- Continue targeting SpO2 94-98% for non-COPD patients 1, 3
- For COPD patients without prior hypercapnic respiratory failure history, may adjust target to 94-98% 1, 3
- For COPD patients with prior hypercapnic respiratory failure, maintain 88-92% target 1, 3
If PCO2 Elevated but pH ≥7.35 (or bicarbonate >28 mmol/L):
- Patient likely has chronic hypercapnia 3
- Maintain target SpO2 88-92% 3
- Continue controlled oxygen delivery 2, 3
If Hypercapnic and Acidotic (pH <7.35):
- Consider non-invasive ventilation (NIV) if respiratory acidosis persists >30 minutes after standard medical management 2
- Maintain SpO2 88-92% target 2
- Never abruptly discontinue oxygen—this causes life-threatening rebound hypoxemia within 1-2 minutes while CO2 remains elevated 2, 3
Adjusting Oxygen Therapy
When to Increase Oxygen:
- If target saturation not achieved, systematically verify equipment function and patient positioning first 1
- For patients with respiratory rate >30 breaths/min, increase Venturi mask flow rates above minimum specified to compensate for increased inspiratory flow 2, 3
- Venturi masks provide more reliable oxygenation than nasal prongs during exercise and acute illness 4
When to Decrease Oxygen:
- Lower oxygen concentration if patient is clinically stable and SpO2 is above target range, or has been in upper zone of target range for 4-8 hours 1
- If target saturation maintained after reduction, continue new delivery system without repeat blood gases if patient stable 1
- Repeat the weaning process gradually 1
Weaning and Discontinuation
Stepwise Approach to Weaning:
- Most stable patients are stepped down to 2 L/min via nasal cannulae prior to cessation 1
- Patients at risk of hypercapnic respiratory failure may require stepping down to 1 L/min (or occasionally 0.5 L/min) via nasal cannulae or 24% Venturi mask at 2 L/min 1
- Stop oxygen once patient is clinically stable on low-concentration oxygen with SpO2 in desired range on two consecutive observations 1
Post-Discontinuation Monitoring:
- Monitor SpO2 on room air for 5 minutes after stopping oxygen 1
- If SpO2 remains in desired range, recheck at 1 hour 1
- Maintain active prescription for target saturation range in case of future deterioration 1
Special Considerations
COPD Patients with Episodic Desaturation:
- Some COPD patients have episodic hypoxaemia during recovery (e.g., intermittent mucus plugging) 1
- Some desaturate when mobilizing despite adequate saturation at rest 1
- Ongoing prescription of target saturation range covers both scenarios 1
Nocturnal Desaturation:
- Approximately 48% of COPD patients on long-term oxygen therapy (LTOT) desaturate during sleep despite adequate daytime oxygenation 5
- Patients with both hypercapnia (PaCO2 ≥45 mmHg) and PaO2 <65 mmHg while breathing oxygen are most likely to desaturate during sleep 5
- Consider increasing oxygen flow by 1 L/min during sleep for COPD patients on LTOT 5
Patients on Established LTOT:
- Taper slowly to usual maintenance oxygen delivery device and flow rate 1
- Senior clinician should consider patient-specific target range if standard range would require inappropriate adjustment of usual oxygen therapy 2, 3
- Do not make decisions about long-term oxygen based on blood gas measurements during acute COPD exacerbations—reassess when stable 1
Common Pitfalls to Avoid
- Excessive oxygen in COPD: 30% of COPD patients receive >35% oxygen in ambulances, and 35% still receive high-concentration oxygen when blood gases are drawn in hospital, contributing to widespread respiratory acidosis 2
- Abrupt oxygen discontinuation in hypercapnic patients: PaO2 plummets within 1-2 minutes while PaCO2 remains elevated, causing potentially fatal hypoxemia 2, 3
- Targeting SpO2 >92% in CO2-retainers: This significantly increases mortality risk through multiple physiological mechanisms 2
- Assuming equipment accuracy: Always verify oximeter function and oxygen delivery system before escalating therapy 1